Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing’s sarcoma, and rhabdomyosarcoma
- Peter Y. Yu
- , Heather L. Gardner
- , Ryan Roberts
- , Hakan Cam
- , Seethalakshmi Hariharan
- , Ling Ren
- , Amy K. Leblanc
- , Hui Xiao
- , Jiayuh Lin
- , Denis C. Guttridge
- , Xiaokui Mo
- , Chad E. Bennett
- , Christopher C. Coss
- , Yonghua Ling
- , Mitch A. Phelps
- , Peter Houghton
- , Cheryl A. London
Producción científica: Article › revisión exhaustiva
14
El enlace se abre en una pestaña nueva
Citas
(Scopus)